Amikacine Fresenius Kabi 5 mg/ml inf. sol. i.v. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

amikacine fresenius kabi 5 mg/ml inf. sol. i.v. vial

fresenius kabi sa-nv - amikacin sulfate 6,68 mg/ml - eq. amikacin 5 mg/ml - solution for infusion - 5 mg/ml - amikacin sulfate 6.68 mg/ml - amikacin

Amikacine Fresenius Kabi 5 mg/ml inf. sol. i.v. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

amikacine fresenius kabi 5 mg/ml inf. sol. i.v. vial

fresenius kabi sa-nv - amikacin sulfate 6,68 mg/ml - eq. amikacin 5 mg/ml - solution for infusion - 5 mg/ml - amikacin sulfate 6.68 mg/ml - amikacin

Amikacine Fresenius Kabi 5 mg/ml inf. sol. i.v. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

amikacine fresenius kabi 5 mg/ml inf. sol. i.v. vial

fresenius kabi sa-nv - amikacin sulfate 6,68 mg/ml - eq. amikacin 5 mg/ml - solution for infusion - 5 mg/ml - amikacin sulfate 6.68 mg/ml - amikacin

Amikacin 5 mg/ml solution for infusion Ireland - English - HPRA (Health Products Regulatory Authority)

amikacin 5 mg/ml solution for infusion

fresenius kabi deutschland gmbh - amikacin - solution for infusion - 5 milligram(s)/millilitre - other aminoglycosides; amikacin

AMIKACIN SULFATE injection, solution United States - English - NLM (National Library of Medicine)

amikacin sulfate injection, solution

fresenius kabi usa, llc - amikacin sulfate (unii: n6m33094fd) (amikacin - unii:84319sgc3c) - amikacin 250 mg in 1 ml - amikacin sulfate injection, usp is indicated in the short-term treatment of serious infections due to susceptible strains of gram-negative bacteria, including pseudomonas species, escherichia coli , species of indole-positive and indole-negative proteus , providencia species, klebsiella species, enterobacter species, serratia species, and acinetobacter species. to reduce the development of drug-resistant bacteria and maintain the effectiveness of amikacin and other antibacterial drugs, amikacin should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. a history of hypersensitivity to amikacin is a contraindication for its use. a history of hypersensitivity or serious toxic react

AMIKACIN 100 mg/2ml FRESENIUS INJECTION South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

amikacin 100 mg/2ml fresenius injection

fresenius kabi manufacturing sa (pty) ltd - injection - see ingredients - each 2 ml vial contains amikacin sulphate equivalent to 100 mg amikacin

AMIKACIN 500 mg/2ml FRESENIUS INJECTION South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

amikacin 500 mg/2ml fresenius injection

fresenius kabi manufacturing sa (pty) ltd - injection - see ingredients - each 2 ml vial contains amikacin sulphate equivalent to 500 mg amikacin

AMIKACIN 1 g/4 ml FRESENIUS INJECTION South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

amikacin 1 g/4 ml fresenius injection

fresenius kabi manufacturing sa (pty) ltd - injection - see ingredients - each 4 ml solution contains amikacin sulphate equivalent to 1 g amikacin

Amikacin - Fresenius 1g/4ml Namibia - English - Namibia Medicines Regulatory Council

amikacin - fresenius 1g/4ml

fresenius kabi manufacturing (sa) (pty) ltd - amikacin sulphate - injection - each 4ml of solution contains:amikacin sulphate equivalent to amikacin 1g

Amikacin - Fresenius 100mg/2ml Namibia - English - Namibia Medicines Regulatory Council

amikacin - fresenius 100mg/2ml

fresenius kabi manufacturing (sa) (pty) ltd - amikacin sulphate - injection - each 2ml of vial contains:amikacin sulphate equivalent to amikacin 100 mg